AGENDIA AT ASBrS

Join the Agendia Sponsored ASBrS Webinar


From NBRST to MINDACT:

The Clinical Utility of BluePrint and MammaPrint in the Pre- and Post-Operative Treatment Settings


Join Us Monday, October 19th, 7:00 pm – 8:00 pm ET, Webinar

Presenter:
Alberto Montero, MD; Director Breast Cancer Program, UH Seidman Cancer Center; Associate Professor, CWRU School of Medicine

Discussant:
James Pellicane, MD; Director of Breast Oncology, Bon Secours Cancer Institute

Description:
Please join our webinar for an interactive discussion of comprehensive genomic profiling and how it can facilitate patient-centered care. Dr. Montero will provide updates on the NBRST and MINDACT clinical trials and discuss the utility of MammaPrint and BluePrint in the pre- and post-operative treatment settings with Dr. Pellicane. We look forward to an impactful webinar and welcome audience participation during the Q&A session.


How to Register:

Register Now For Monday, October 19

Dr. Montero

Alberto Montero, MD, MBA, CPHQ, is clinical director of the Breast Cancer Medical Oncology Program at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University School of Medicine. He is board certified in medical oncology by the American Board of Internal Medicine.Dr. Montero has been in academic practice for over 13 years and has demonstrated a strong track record of clinical research in breast cancer. Prior to joining the UH Seidman Cancer Center team, Dr. Montero spent seven years at the Cleveland Clinic, where he served as a staff physician in the hematology and oncology department, as well as chief quality improvement officer and patient experience officer. Before that, Dr. Montero was on staff at University of Miami Sylvester Cancer Center as Breast Cancer Site Disease Group co-leader, and at the Medical University of South Carolina Division of Hematology/Oncology.

Dr. Pellicane

Dr. James Pellicane received his undergraduate degree from The Johns Hopkins University and his medical degree from the University of Pittsburgh School of Medicine. He completed his General Surgery residency at Virginia Commonwealth University The Medical College of Virginia and is board certified by the American Board of Surgery.

He is a fellow of the American College of Surgeons and is an active member of The American Society of Breast Surgeons. He co-founded Virginia Breast Center in 2005 and affiliated with Bon Secours in 2008 now with 3 surgeons serving all 4 Bon Secours hospitals in Richmond. Dr. Pellicane currently is the Director of Breast Oncology at the Bon Secours Cancer Institute in Richmond, VA.

FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Completed Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

See the mindact trial

Latest News

Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients […]

Read the article

Patient News

Agendia and artist Andrea Caceres go “beyond the mammogram” in a portrait series illustrating people touched by breast cancer.

View the documentary

For the US, Puerto Rico, and South America

Agendia Inc. USA
22 Morgan
Irvine, CA 92618
(888) 321-2732
[email protected]


For outside the Americas

Agendia NV
Radarweg 60
1043 NT Amsterdam
The Netherlands
[email protected]
+31 (0)20 462 1510